# Heterotopic Ossification in Neurorehabilitation

## Introduction

Heterotopic ossification (HO) is the formation of mature lamellar bone in extraskeletal soft tissues, most commonly periarticular muscles and connective tissue. It is a frequent and debilitating complication encountered in neurorehabilitation settings, particularly after traumatic brain injury (TBI), spinal cord injury (SCI), and major burns. Early recognition and intervention are critical to preserving joint mobility and functional outcomes.

## Epidemiology and Risk Factors

**Traumatic brain injury**: HO incidence ranges from 10-20%, with clinically significant HO in 5-10%. **Spinal cord injury**: reported incidence of 20-30%, predominantly below the level of injury. **Burns**: incidence of 1-3% overall, higher in burns exceeding 30% total body surface area. Risk factors include prolonged immobilization, spasticity, prolonged coma (GCS less than 8), associated long bone fractures, and mechanical ventilation exceeding 2 weeks. The hip is the most commonly affected joint, followed by the elbow, shoulder, and knee.

## Pathophysiology

HO results from aberrant differentiation of **mesenchymal stem cells** into osteoblasts within soft tissue. Three conditions are required: an osteogenic precursor cell, an inducing agent, and a permissive tissue environment. **Bone morphogenetic proteins (BMPs)**, particularly BMP-2 and BMP-4, play a central role in signaling pathways. Neurogenic inflammation, local hypoxia, and venous stasis contribute to the permissive microenvironment. Prostaglandin E2 (PGE2) mediates inflammatory signaling that promotes ectopic bone formation.

![Histological progression of heterotopic ossification from early fibroproliferative stage to mature lamellar bone](histology-ho-progression.png)

## Clinical Presentation

Early signs include localized **swelling, warmth, erythema**, and decreased range of motion. Pain may be present in patients with preserved sensation but is absent in complete SCI. Differential diagnosis includes deep vein thrombosis (DVT), cellulitis, abscess, fracture, and tumor. Late presentation features a palpable, firm periarticular mass with progressive joint ankylosis. HO and DVT frequently coexist; both should be evaluated concurrently.

### Brooker Classification (Hip HO)

**Class I**: Islands of bone within soft tissue. **Class II**: Bone spurs from pelvis or proximal femur with gap greater than 1 cm. **Class III**: Bone spurs with gap less than 1 cm. **Class IV**: Complete bony ankylosis of the joint.

| Brooker Class | Description | Clinical Impact |
|--------------|-------------|-----------------|
| I | Islands of bone within soft tissue | Minimal functional limitation |
| II | Bone spurs with gap >1 cm | Moderate ROM restriction |
| III | Bone spurs with gap <1 cm | Significant ROM loss |
| IV | Complete bony ankylosis | Total loss of joint motion |

## Diagnostic Evaluation

**Serum alkaline phosphatase (ALP)**: elevated early, nonspecific; useful for monitoring disease activity. **Triple-phase bone scan**: most sensitive early test; positive 2-4 weeks before radiographic changes. **Plain radiographs**: visible calcification appears 4-6 weeks after onset; useful for classification. **CT scan**: gold standard for defining mature HO architecture prior to surgical planning. **Ultrasound**: emerging modality for early detection in bedside settings; shows zone phenomenon.

![Three-phase bone scan demonstrating increased uptake at the left hip consistent with early heterotopic ossification](bone-scan-ho.png)

## Prevention

**NSAIDs**: indomethacin 75 mg/day for 3-6 weeks is the most established pharmacologic prophylaxis. **Radiation therapy**: single-dose 700-800 cGy within 72 hours of injury or surgery; effective but limited availability. **Range of motion exercises**: gentle, pain-free ROM; aggressive stretching may paradoxically worsen HO. **Etidronate disodium**: first-generation bisphosphonate; delays mineralization but does not prevent osteoid formation. Prophylaxis is indicated in high-risk populations (severe TBI with prolonged coma, SCI with spasticity).

## Treatment

### Conservative Management

Maintain functional range of motion with gentle stretching and positioning programs. Serial casting or dynamic splinting for progressive contracture. NSAIDs for anti-inflammatory effect and pain control. Physical and occupational therapy to preserve ADL function.

### Surgical Excision

Indicated when HO causes significant functional limitation, nerve entrapment, or skin breakdown. Traditionally delayed until bone maturation (12-18 months), confirmed by normalization of ALP and cold bone scan. Recent evidence supports earlier excision (6 months) with perioperative prophylaxis. **Perioperative prophylaxis** with indomethacin or radiation is essential to reduce recurrence (15-20% recurrence rate).

![Lateral radiograph of the elbow showing mature heterotopic ossification causing near-complete ankylosis](elbow-ho-radiograph.png)

## Rehabilitation Considerations

Interdisciplinary team approach involving physiatry, orthopedic surgery, radiology, and therapy services. Monitor joint ROM serially with goniometry; document in therapy notes. Balance aggressive mobilization against the risk of exacerbating inflammation. Address associated complications: pressure injuries from immobility, peripheral nerve compression (ulnar nerve at elbow HO), and vascular compromise. Long-term follow-up is necessary as recurrence can occur months to years after intervention.

## Key Clinical Pearls

Always consider DVT in the differential when a neurorehabilitation patient presents with unilateral limb swelling; HO and DVT frequently coexist. Triple-phase bone scan is the most sensitive early diagnostic test, detecting HO weeks before plain radiographs. Gentle ROM is protective; aggressive passive stretching beyond the pain-free range may promote HO formation. Surgical excision should be paired with perioperative prophylaxis (NSAIDs or radiation) to minimize recurrence. Serum alkaline phosphatase trending downward and a cold bone scan suggest HO maturation and readiness for surgical intervention.

## References

1. Ranganathan K, Loder S, Agarwal S, et al. Heterotopic ossification: basic-science principles and clinical correlates. *Journal of Bone and Joint Surgery*. 2015;97(13):1101-1111.
2. Cipriano CA, Pill SG, Keenan MA. Heterotopic ossification following traumatic brain injury and spinal cord injury. *Journal of the American Academy of Orthopaedic Surgeons*. 2009;17(11):689-697.
3. Sullivan MP, Torres SJ, Mehta S, Ahn J. Heterotopic ossification after central nervous system trauma: a current review. *Bone & Joint Research*. 2013;2(3):51-57.
4. Meyers C, Lisiecki J, Miller S, et al. Heterotopic ossification: a comprehensive review. *JBMR Plus*. 2019;3(4):e10172.